These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9495222)

  • 21. Pharmacokinetics of anti-HIV nucleosides in microswine.
    Swagler AR; Qian MX; Gallo JM
    J Pharm Pharmacol; 1991 Dec; 43(12):823-6. PubMed ID: 1687578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
    Zhou XJ; Sheiner LB; D'Aquila RT; Hughes MD; Hirsch MS; Fischl MA; Johnson VA; Myers M; Sommadossi JP
    Antimicrob Agents Chemother; 1999 Jan; 43(1):121-8. PubMed ID: 9869576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of spontaneous gastric hypoacidity on the pharmacokinetics of zidovudine and didanosine.
    Shelton MJ; Adams JM; Hewitt RG; Steinwandel C; DeRemer M; Cousins S; Morse GD
    Pharmacotherapy; 1997; 17(3):438-44. PubMed ID: 9165548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hypokalemia and hypomagnesemia on zidovudine (AZT) and didanosine (ddI) nephrotoxicity in rats.
    Seguro AC; de Araujo M; Seguro FS; Rienzo M; Magaldi AJ; Campos SB
    Clin Nephrol; 2003 Apr; 59(4):267-72. PubMed ID: 12708566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
    Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.
    Li RC; Narang PK; Sahai J; Cameron W; Bianchine JR
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1566-70. PubMed ID: 9210686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.
    Barry M; Howe JL; Ormesher S; Back DJ; Breckenridge AM; Bergin C; Mulcahy F; Beeching N; Nye F
    Br J Clin Pharmacol; 1994 May; 37(5):421-6. PubMed ID: 8054247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropositive patients.
    Anderson RD; Griffy KG; Jung D; Dorr A; Hulse JD; Smith RB
    Clin Ther; 1995; 17(3):425-32. PubMed ID: 7585846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem?
    Sanne I; Smego RA; Mendelow BV
    Int J Infect Dis; 2001; 5(1):43-8. PubMed ID: 11285159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.
    Wang Y; Livingston E; Patil S; McKinney RE; Bardeguez AD; Gandia J; O'Sullivan MJ; Clax P; Huang S; Unadkat JD
    J Infect Dis; 1999 Nov; 180(5):1536-41. PubMed ID: 10515813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic evaluation of drug interactions with zidovudine. I: Probenecid and zidovudine in monkeys.
    Qian MX; Finco TS; Mehta M; Viswanathan CT; Gallo JM
    J Pharm Sci; 1991 Nov; 80(11):1007-11. PubMed ID: 1815049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers.
    Hedaya MA; Elmquist WF; Sawchuk RJ
    Pharm Res; 1990 Apr; 7(4):411-7. PubMed ID: 2362917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
    Cooper EC
    AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults.
    McDowell JA; Lou Y; Symonds WS; Stein DS
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2061-7. PubMed ID: 10898676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients.
    Massarella JW; Nazareno LA; Passe S; Min B
    Pharm Res; 1996 Mar; 13(3):449-52. PubMed ID: 8692740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
    Sölder B; Wintergerst U; Notheis G; Eberle J; Gürtler L; Belohradsky BH
    J Pediatr; 1997 Feb; 130(2):293-9. PubMed ID: 9042135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.
    Domanski MJ; Sloas MM; Follmann DA; Scalise PP; Tucker EE; Egan D; Pizzo PA
    J Pediatr; 1995 Jul; 127(1):137-46. PubMed ID: 7608800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of zidovudine and didanosine during combination therapy.
    Morse GD; Shelton MJ; Ho M; Bartos L; DeRemer M; Ragni M
    Antiviral Res; 1995 Aug; 27(4):419-24. PubMed ID: 8540760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACTG 152: new insights into pediatric antiretroviral therapy.
    Bowersox J
    NIAID AIDS Agenda; 1996 Mar; ():3. PubMed ID: 11363798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.